The FASEB Journal, Vol 3, 44-51, Copyright © 1989 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells

TA Voyno-Yasenetskaya, VA Tkachuk, EG Cheknyova, MP Panchenko, GY Grigorian, RJ Vavrek, JM Stewart and US Ryan
Laboratory for Molecular Endocrinology, National Cardiology Research Center, Moscow, USSR.

In this paper we examine the effect of the vasodilator peptide bradykinin on endothelial cell regulation of phosphoinositide (PI) turnover. The data show that the activation of PI turnover by bradykinin in bovine pulmonary artery endothelial cells is insensitive to pertussis toxin, which ADP ribosylates a membrane protein of mol wt 40,000. However, this effect of bradykinin can be potentiated by guanosine 5'-O-(3-thio)triphosphate (GTP gamma S), an activator of G proteins, and depressed by guanosine 5'-O-(2-thio)diphosphate (GDP beta S), an inhibitor of G proteins. After endothelial cells were preincubated for 1 h with GTP gamma S, there was a three- to fourfold increase in PI turnover. Preincubation of cells with GDP beta S did not affect the basal level of PI turnover, but completely prevented activation of PI turnover by bradykinin. 4 beta-Phorbol-12 beta- myristate-13 alpha-acetate can block the bradykinin-stimulated inositol monophosphate formation in cultured endothelial cells. The effects of bradykinin on PI turnover were blocked by B2 antagonists but not by B1 antagonists. Taken together, these results indicate that in endothelial cells the bradykinin B2 receptor is coupled to phospholipase C via a G protein (or proteins) that is not a substrate for pertussis toxin (neither Gi nor Go).

This article has been cited by other articles:

				L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF]

				A. Pizard, J. Marchetti, J. Allegrini, F. Alhenc-Gelas, and R. M. Rajerison Negative Cooperativity in the Human Bradykinin B2 Receptor J. Biol. Chem., January 16, 1998; 273(3): 1309 - 1315. [Abstract] [Full Text] [PDF]

				R. H. Ritchie, J. D. Marsh, W. D. Lancaster, C. A. Diglio, and R. J. Schiebinger Bradykinin Blocks Angiotensin II-Induced Hypertrophy in the Presence of Endothelial Cells Hypertension, January 1, 1998; 31(1): 39 - 44. [Abstract] [Full Text]

				H. Karaki, H. Ozaki, M. Hori, M. Mitsui-Saito, K.-I. Amano, K.-I. Harada, S. Miyamoto, H. Nakazawa, K.-J. Won, and K. Sato Calcium Movements, Distribution, and Functions in Smooth Muscle Pharmacol. Rev., June 1, 1997; 49(2): 157 - 230. [Abstract] [Full Text] [PDF]

				J. A. Panza, C. E. Garcia, C. M. Kilcoyne, A. A. Quyyumi, and R. O. Cannon III Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension : Evidence That Nitric Oxide Abnormality Is Not Localized to a Single Signal Transduction Pathway Circulation, March 15, 1995; 91(6): 1732 - 1738. [Abstract] [Full Text]

				D. Communi, E. Raspe, S. Pirotton, and J.-M. Boeynaems Coexpression of P2Y and P2U Receptors on Aortic Endothelial Cells : Comparison of Cell Localization and Signaling Pathways Circ. Res., February 1, 1995; 76(2): 191 - 198. [Abstract] [Full Text]

				J. F. Seccombe, P. J. Pearson, and H. V. Schaff Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 505 - 509. [Abstract] [Full Text]

				A. Gilchrist, J. F. Vanhauwe, A. Li, T. O. Thomas, T. Voyno-Yasenetskaya, and H. E. Hamm Galpha Minigenes Expressing C-terminal Peptides Serve as Specific Inhibitors of Thrombin-mediated Endothelial Activation J. Biol. Chem., July 6, 2001; 276(28): 25672 - 25679. [Abstract] [Full Text] [PDF]